Stay updated on APR-246 & Azacitidine in TP53 MDS Clinical Trial
Sign up to get notified when there's something new on the APR-246 & Azacitidine in TP53 MDS Clinical Trial page.

Latest updates to the APR-246 & Azacitidine in TP53 MDS Clinical Trial page
- Check3 days agoChange DetectedThe page shows a new latest revision tag, v3.5.4, replacing the previous v3.5.3, indicating a platform update rather than a data change.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page’s displayed software/version label was updated from **v3.5.0** to **v3.5.3**, indicating a minor interface or release revision without changing the study record details shown on the page.SummaryDifference0.1%

- Check54 days agoChange DetectedA new 'More Information' entry was added to the study record history on 2025-03-06. Core study details such as status and results are unchanged.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page history.SummaryDifference0.2%

- Check75 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the version history.SummaryDifference0.2%

- Check96 days agoChange DetectedThe record history adds a new revision entry (v3.4.2) and removes the previous revision (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to APR-246 & Azacitidine in TP53 MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APR-246 & Azacitidine in TP53 MDS Clinical Trial page.